Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Deficit, Unaudited

v3.24.2.u1
Condensed Consolidated Statement of Stockholders' Deficit, Unaudited - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 376,075 $ 119,075,925 $ (124,142,000) $ (4,690,000)
Beginning balance, shares at Dec. 31, 2022 376,074,096      
Common stock issued on conversion of notes payable $ 8,629 161,371 170,000
Common stock issued on conversion of notes payable, shares 8,628,664      
Relative fair value of warrants issued with convertible notes 103,000 103,000
Common stock issued on exercise of warrants, shares 1,116,662      
Fair value of options and warrants issued as compensation 14,000 14,000
Common stock issued on exercise of warrants 1,117 40,883 42,000
Ending balance, value at Jun. 30, 2023 385,821 119,395,179 (124,760,000) (4,979,000)
Net loss (618,000) (618,000)
Ending balance, shares at Jun. 30, 2023 385,819,422      
Beginning balance, value at Mar. 31, 2023 $ 384,538 119,306,462 (124,476,000) (4,785,000)
Beginning balance, shares at Mar. 31, 2023 384,537,426      
Common stock issued on conversion of notes payable $ 1,149 24,851 26,000
Common stock issued on conversion of notes payable, shares 1,148,664      
Relative fair value of warrants issued with convertible notes 56,000 56,000
Common stock issued on exercise of warrants, shares 133,332      
Fair value of options and warrants issued as compensation 5,000 5,000
Common stock issued on exercise of warrants 134 2,866 3,000
Ending balance, value at Jun. 30, 2023 385,821 119,395,179 (124,760,000) (4,979,000)
Net loss (284,000) (284,000)
Ending balance, shares at Jun. 30, 2023 385,819,422      
Beginning balance, value at Dec. 31, 2023 $ 392,587 119,729,413 (125,366,000) (5,244,000)
Beginning balance, shares at Dec. 31, 2023 392,586,471      
Common stock issued on conversion of notes payable $ 7,062 119,938 127,000
Common stock issued on conversion of notes payable, shares 7,062,000      
Warrants issued with convertible notes 190,000 190,000
Common stock issued upon exercise of warrants $ 433 17,567 18,000
Common stock issued upon exercise of warrants, shares 433,329      
Common stock issued for services $ 2,000 138,000 140,000
Common stock issued for services, shares 2,000,000      
Relative fair value of warrants issued with convertible notes 9,000 9,000
Ending balance, value at Jun. 30, 2024 402,082 120,203,918 (126,148,000) (5,542,000)
Net loss (782,000) (782,000)
Ending balance, shares at Jun. 30, 2024 402,081,800      
Beginning balance, value at Mar. 31, 2024 $ 397,932 120,035,068 (125,815,000) (5,382,000)
Beginning balance, shares at Mar. 31, 2024 397,931,803      
Common stock issued on conversion of notes payable $ 3,850 46,150 50,000
Common stock issued on conversion of notes payable, shares 3,850,000      
Warrants issued with convertible notes 105,000 105,000
Common stock issued upon exercise of warrants $ 300 13,700 14,000
Common stock issued upon exercise of warrants, shares 299,997      
Relative fair value of warrants issued with convertible notes 4,000 4,000
Ending balance, value at Jun. 30, 2024 402,082 120,203,918 (126,148,000) (5,542,000)
Net loss $ (333,000) $ (333,000)
Ending balance, shares at Jun. 30, 2024 402,081,800